Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369950 · ClinicalTrials.gov registry record · Phase 4
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT04369950 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 44 participants.
The verdict
NCT04369950, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epinephrine on total opioid use for 24h
Interventions
- DRUG 2% lidocaine with 1:200,000 epinephrine and epidural morphine
- DRUG 3% 2-chloroprocaine and epidural morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-05-11 |
| Est. Completion | 2021-07-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04369950
The ClinicalTrials.gov registry entry for NCT04369950 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2% lidocaine with 1:200,000 epinephrine and epidural morphine is the first listed.
NCT04369950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04369950 about?
NCT04369950 is a clinical study titled "Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine". The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epinephrine on total opioid use for 24h
What is the current status of trial NCT04369950?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2020-05-11. Estimated completion is 2021-07-11.
What interventions are being tested in trial NCT04369950?
The interventions under investigation include: 2% lidocaine with 1:200,000 epinephrine and epidural morphine (DRUG), 3% 2-chloroprocaine and epidural morphine (DRUG).
Who is sponsoring clinical trial NCT04369950?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.